Gian Life Care Ltd.
Snapshot View

25.85 ▼0%

04 October 2022, 04:01:00 PM

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.gianpathlabs.com
Market Cap 26.73 Cr.
Enterprise Value(EV) 25.23 Cr. 2021-03
Financial Indicators
Earnings per share (EPS) 4.23 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 6.11 Trailing Twelve Months Ending 2022-03
Industry PE 50.40 Trailing Twelve Months Ending 2022-03
Book Value / Share 17.62 Trailing Twelve Months Ending 2022-03
Price to Book Value 1.47 Calculated using Price: 25.85
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 1.03 Cr. 10,341,527 Shares
FaceValue 10
Company Profile
The company is engaged in the business of providing diagnostic and related healthcare services. The company provides a wide range of diagnostic tests and services like patient diagnosis services, prevention, and wellness diagnosis services to patients and healthcare providers. The company caters to individual patients, hospitals, corporates and other healthcare providers. The company offers various tests including biochemistry, clinical pathology, coagulation, cytogenetics, cytology, hematology, histopathology, immunoassay, microbiology, molecular biology, and radiology services.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
+3.40%
1 Month
-15.25%
3 Month
-13.11%
6 Month
-36.41%
1 Year
-51.60%
2 Year
+133.09%
5 Year
10 Year
3 years 2019-03 2020-03 2021-03
Return on Equity (%) 90.94 29.34 23.33
Return on Capital Employed (%) 12.26 42.76 35.91
Return on Assets (%) 1.28 11.16 14.49

Balance Sheet View Details >>

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Shh. Funds 0 8 10
Non Curr. Liab. 1 1 1
Curr. Liab. 7 4 5
Minority Int.
Equity & Liab. 8 12 15
Non Curr. Assets 4 8 9
Curr. Assets 3 4 6
Misc. Exp. not W/O
Total Assets 8 12 15

Profit Loss View Details >>

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Net Sales 1 8 10
Other Income 0 0
Total Income 1 8 11
Total Expenditure 0 -5 -7
PBIDT 0 2 4
Interest 0 -1 -1
Depreciation 0 0 0
Taxation 0 0 -1
Exceptional Items
PAT 0 1 2
Adjusted EPS 0 1 2

Cash Flow View Details >>

Particulars 3 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 3 2 3
Cash Fr. Inv. -3 -4 -1
Cash Fr. Finan. 1 3 0
Net Change 1 0 1
Cash & Cash Eqvt 1 1 3

Shareholding Pattern View Details >>

5 Qtrs 2020-03 (%) 2020-09 (%) 2021-03 (%) 2021-09 (%) 2022-03 (%)
Promoter 69.87 69.87 69.87 69.87 64.95
Public 30.13 30.13 30.13 30.13 35.05
Depository Receipts 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Sat, 01 Oct 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM
Dear Sir Please find enclosed herewith a copy of proceedings of the 4th Annual General Meeting of the Company held on Friday September 30 2022.This is for your reference and record.Yours faithfully For Gian Life Care Limited
Sat, 01 Oct 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM
Please find enclosed herewith correct copy of proceedings of the 4th Annual General Meeting of the Company held on Friday September 30 2022. Kindly ignore the previous outcome due to some typographical error.This is for your reference and recordYours faithfully For Gian Life Care Limited
Sat, 01 Oct 2022
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
The 4th Annual General Meeting ("AGM") of Gian Life Care Limited was held on Friday 30th September 2022 at 09:30 A.M at the Registered Office of the company.The consolidated report of the Scrutinizer on remote e-voting prior and during the 4th Annual General Meeting of the company is attached herewith along with voting results.Please take the same on record.Thanking You For Gian Life Care Limited

Technical Scans View Details >>

Tue, 04 Oct 2022
High Delivery Percentage High Delivery Percentage
Close Crossing Last Month Close From Below Close Crossing Last Month Close From Below
Opening at High Opening at High
Closing Above Previous High Closing Above Previous High
High Decrease 1 Month High Decrease 1 Month

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 228,896.56 954.00 +1.2%
Divi's Laboratories Ltd. 99,171.10 3,735.70 -1.2%
Cipla Ltd. 91,534.16 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. 73,236.99 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. 63,161.01 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. 54,354.34 1,606.00 +0.9%
Zydus Lifesciences Ltd. 42,831.42 423.15 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.85 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-06 31.94 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-06 36.78 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.49 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.49 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 67.86 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-06 9.69 423.15 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.57 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-06 4.26 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.62 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.50 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-06 2.55 423.15 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 0.04 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 423.15 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 423.15 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 423.15 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 423.15 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 954.00 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,735.70 -1.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,134.25 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,399.50 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,392.75 -0.2%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,606.00 +0.9%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 423.15 +0.8%

FAQ's On Gian Life Care Ltd.

What is Gian Life Care share price?

Can I buy Gian Life Care shares now?

What is the Market Cap of Gian Life Care?

What are the key metrics to analyse Gian Life Care?

What is the 52 Week High and Low of Gian Life Care?